Amphastar Asks Justices Not To Review Drug Safe Harbor
Amphastar Pharmaceuticals Inc. urged the U.S. Supreme Court on Friday to reject an appeal over the scope of the Hatch-Waxman Act's safe harbor provision, saying the Federal Circuit correctly interpreted the...To view the full article, register now.
Already a subscriber? Click here to view full article